Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Cash Flow Reinvestment Rate
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Cash Flow Reinvestment Rate of 0.09x as of September 2025, reinvesting CN¥63.68 Million (capex CN¥63.68 Million ) from operating cash flow of CN¥670.83 Million. Check Shanghai Allist Pharmaceuticals Co. Ltd. (688578) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Shanghai Allist Pharmaceuticals Co. Ltd. A Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Shanghai Allist Pharmaceuticals Co. Ltd. A across 6 annual periods. Explore how well can Shanghai Allist Pharmaceuticals Co. Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2025)
Year-by-year capital reinvestment analysis for Shanghai Allist Pharmaceuticals Co. Ltd. A. For live market cap and broader valuation context, see 688578 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | CN¥278.90 Million | CN¥2.32 Billion | CN¥186.00 Million | ▼ -45.5% |
| 2024 | 0.22x | CN¥345.07 Million | CN¥1.57 Billion | CN¥270.22 Million | ▼ -7.5% |
| 2023 | 0.24x | CN¥160.63 Million | CN¥674.65 Million | CN¥67.88 Million | ▼ -96.0% |
| 2022 | 5.98x | CN¥548.05 Million | CN¥91.63 Million | CN¥143.83 Million | ▼ -59.4% |
| 2021 | 14.73x | CN¥431.43 Million | CN¥29.29 Million | CN¥192.25 Million | ▲ +10574.3% |
| 2017 | 0.14x | CN¥1.40 Million | CN¥10.11 Million | CN¥1.40 Million | — |